Nachrichten zur Vertex Pharmaceuticals Aktie

AKTIONÄR-Depotwert Vertex: Potenzial wie Wegovy? - Aktie auf Rekordhoch

In dieser Handelswoche hat die Aktie des Biotech-Unternehmens Vertex Pharmaceuticals ein frisches Rekordhoch markiert. Geht es nach David Risinger, Analyst…

AKTIONÄR-Depotwert Vertex: Potenzial wie Wegovy? – Aktie auf Rekordhoch

In dieser Handelswoche hat die Aktie des Biotech-Unternehmens Vertex Pharmaceuticals ein frisches Rekordhoch markiert. Geht es nach David Risinger, Analyst…

Verdoppler-Potenzial: CRISPR-Therapeutics-Aktie haussiert: Darum geht Cathie Woods Wette auf

CRISPR Therapeutics hebt ab: Meilenstein rückt näher – auch AKTIONÄR-Depotwert Vertex profitiert

Der Gen-Schere-Spezialist CRISPR Therapeutics und sein Entwicklungspartner Vertex Pharmaceuticals sind der ersten Marktzulassung einer CRISPR/Cas9-basierten Therapie einen Schritt näher gekommen.…

: Crispr Therapeutics’ stock soars premarket after positive meeting of FDA panel on sickle-cell-disease therapy

Crispr Therapeutics AG’s stock CRSP rallied 17% in premarket trade Wednesday, after a positive meeting of a Food and Drug…

Vertex Pharmaceuticals: Buy at the High?

Vertex shares have been flying high in recent times.…

Vertex Pharmaceuticals: Buy at the High? @themotleyfool #stocks $VRTX $CRSP $MRNA

Vertex shares have been flying high in recent times.…

Vertex Pharmaceuticals executive chairman disposes stake worth $4.85M

…

AKTIONÄR-Depotwert Vertex: Nächste Zulassung, neues Rekordhoch

Als unangefochtener Weltmarktführer für Mukoviszidose-Arzneimittel besetzt Vertex Pharmaceuticals seit Jahren eine lukrative Nische. Entsprechend hoch ist die Preissetzungsmacht und die…

Vertex Pharmaceuticals: Weiterer Zulassungserfolg für Top-Seller Trikafta - Kein Stück aus der Hand geben! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Vertex Pharmaceuticals Inc.…

AKTIONÄR-Depotwert Vertex: Nächste Zulassung, neues Rekordhoch

Als unangefochtener Weltmarktführer für Mukoviszidose-Arzneimittel besetzt Vertex Pharmaceuticals seit Jahren eine lukrative Nische. Entsprechend hoch ist die Preissetzungsmacht und die…

Is Vertex Pharmaceuticals Stock a Buy Now? @themotleyfool #stocks $VRTX

Jim Cramer recently hyped up one of the companys promising drugs.…

Is Vertex Pharmaceuticals Stock a Buy Now?

Jim Cramer recently hyped up one of the companys promising drugs.…

Vertex Pharmaceuticals: Umsatzwachstum durch potenzielle Erweiterung der Pipeline - Aktienanalyse

Charlotte (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BofA Securities: Die Analysten von BofA Securities erhöhen in einer aktuellen Aktienanalyse ihr Kursziel für…

Cramer says Vertex has a drug that may address the largest market opportunity in the world

CNBCs Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.…

AKTIONÄR-Depotwert Vertex: Unglaublich stark – nächsten Mega-Märkte im Blick

Unter den großen Biotech-Werten glänzt das Papier von Vertex Pharmaceuticals nach wie vor mit einer hohen Relativen Stärke. Der AKTIONÄR-Depottitel…

Vertex Pharmaceuticals: Aussichten von VX-548 im Fokus - Aktienanalyse

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Brian Abrahams, Analyst von RBC Capital Markets, erhöht in einer aktuellen Aktienanalyse…

Insiderhandel: EVP, Chief Reg. & Quality Off. verkauft Aktien von Vertex Pharmaceuticals im Wert von 887.500$

Tatsis, Ourania - Vorstand - Tag der Transaktion: 2023-08-23...…

Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?

Vertex stock has been a growth beast in recent years -- can that trend continue?...…

Is Vertex Pharmaceuticals Stock a Buy Now?

Its got upcoming catalysts, strong earnings, and a solid base of sales, too....…

AKTIONÄR-Depotwert Vertex: Frische Daten – der nächste Blockbuster?

Das Unternehmen Vertex Pharmaceuticals zählt zu den größten Erfolgsstorys in der internationalen Biotech-Szene. Mit der Entwicklung von Medikamenten zur Behandlung…

Vertex (VRTX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended…

Company News for Aug 3, 2023

Companies in The News Are: VRTX, DVN, AFL, HUM...…

Pfizer: Bringen die Quartalsergebnisse den Turnaround?

Pharmawerte lagen die letzten Monate über eigentlich recht gut im Rennen und Titel wie Eli Lilly oder Vertex Pharmaceuticals führten…

Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2023....…

Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Top Estimates

Vertex (VRTX) delivered earnings and revenue surprises of 1.04% and 3.47%, respectively, for the quarter ended June 2023. Do the…

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

...(Reuters) - Vertex Pharmaceuticals raised its full-year sales......…

Vertex Pharmaceuticals Inc. Q2 Profit Increases, beats estimates

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) revealed a profit for its second quarter that increased from the same…

Vertex Pharmaceuticals 2Q Profit Up On Higher Cystic Fibrosis Drug Revenue

Vertex Pharmaceuticals 2Q Profit Up On Higher Cystic Fibrosis Drug Revenue...…

Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire?

The biotech is currently firing on all cylinders, but can it last?...…

2 No-Brainer Cathie Wood Stocks to Buy Right Now

Vertex Pharmaceuticals and Pfizer should be stellar long-term buys....…

Vortex Energy Announces Further Extension of Marketing Campaign

VANCOUVER, British Columbia, July 21, 2023 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX | OTC: VTECF |…

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $358.57, moving -0.11% from the previous trading session....…

Vertex Pharmaceuticals: Buy at the High?

Vertexs next blockbuster may be right around the corner....…

3 Things About Vertex Pharmaceuticals That Smart Investors Know

Vertex shares have advanced about 20% so far this year....…

Atco Mining Engages Respec to Advance its Eagle and Flat Bay Salt Projects in Southwestern Newfoundland

Vancouver, British Columbia - TheNewswire - July 11, 2023 - Atco Mining Inc. (the “Company” or “Atco”) (CSE:ATCM) (OTC:ATMGF) (Frankfurt:QP9)…

Sitting on Cash? These 2 Stocks Are Great Buys

Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term....…

Vertex Pharmaceuticals (VRTX) Stock Moves -0.73%: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $345.76, moving -0.73% from the previous trading session....…

Vertex (VRTX) Gets Nod in EU for Orkambi Expanded Indication

Vertexs (VRTX) Orkambi gets approval from the European Commission in the EU for the treatment of cystic fibrosis in patients…

Vertex Pharmaceuticals Stock: Bear vs. Bull

Vertex has reached a key moment in its story....…

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $348.18, moving -0.74% from the previous trading session....…

Vertex Pharma, Lonza Collaborate To Build Manufacturing Facility For Type 1 Diabetes Cell Therapies

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc (VRTX) and Lonza (LONN.SW) have announced a strategic collaboration aimed at supporting the…

Analyst Ratings for Vertex Pharmaceuticals

Latest Ratings for VRTX DateFirmActionFromTo Feb 2022RBC CapitalDowngradesOutperformSector Perform Jan 2022BMO CapitalUpgradesMarket PerformOutperform Dec 2021Wells FargoInitiates Coverage OnOverweight …

Alleged Industrial Espionage Makes an Interesting Story

We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment....…

Vertex Pharmaceuticals (VRTX) Stock Moves -0.34%: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $347.89, moving -0.34% from the previous trading session....…

Vortex Energy ernennt den ehrenwerten George J. Furey zum Berater und meldet Gewährung von Optionen

14. Juni 2023 Vancouver, British Columbia / IRW-Press / Vortex Energy Corp. (CSE: VRTX | OTC: VTECF |…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $334.11, moving +0.46% from the previous trading session....…

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Today, CRISPR has reached an important turning point....…

Insiderhandel: SVP & Chief Accounting Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 95.318$

Ambrose, Kristen - Vorstand - Tag der Transaktion: 2023-05-30...…

Vortex Energy schließt seismische Untersuchung ab

1. Juni 2023 Vancouver, British Columbia / IRW-Press / — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FWB:…

dpa-AFX ProFeed